Solid Dosage Form Development Platform
Topical Formulation
Development Platform
Oral Film Form
Development Platform
Commercial Manufacturing

Innovative Product Development and Commercialization

Improving drug absorption through solid-state technology is the foundation of all our innovative technologies.

Advantages of Solid-State Technology in Drug Formulations

New Drugs
全新药
Solid Form Screening and Intellectual Property Layout
Improved Drugs
改良药
Enhancing Bioavailability/Safety
Generic Pharmaceuticals
仿制药

Ensuring Consistency in Drug Substance Quality

Our Technological Advantages

Optimal Bioavailability


Development of a Next-Generation Amorphous Drug Development System and a Systematic Co-crystal Screening and Evaluation System, ensuring each compound achieves "

optimal bioavailability."

One-Stop Development Platform

A tightly integrated formulation development and industrialization platform ensures that each solid-state drug form achieves optimal compatibility and delivery efficiency.

Specialized Solid State Formulation Team

The core team possesses nearly 20 years of experience in the development and industrialization of crystal formulations, excelling in both innovative and generic drugs, swiftly overcoming technical challenges and gaining a competitive edge.
Specializing in the development of multiple patented improved solid-state formulations.

Amorphous Solid Dispersions and Co-crystals

Platform for Solid State Formulation Improvement and Formulation Innovation

Caption: Improved innovative product NY-1047 receives excellent biological response feedback.
The Solid State of a drug significantly affects its dissolution rate.
■  The solubility differences between different crystal forms of compounds can vary by 2-3 times. ■  Co-crystals may enhance drug solubility by approximately 5 times. ■  Amorphous forms, however, can potentially increase solubility by more than 10 times.
PXRD、Raman Spectroscopy、DSC、TGA、DVS、Particle Size Analyze、Parallel Crystallizer、 Polarized Light Microscope、Spray Dryer、 Fully Automated Grinder、High Performance Liquid Chromatography、Tablet Press、Film Coater
最优生物利用度

全新一代无定型药物开发系统,以及系统性共晶筛选和评价体系,保证每一个化合物获得“生物利用度最优解”。
一站式开发平台

衔接紧密的制剂开发及产业化平台,确保每一种固态药物形式获得最佳的相容性和递送效率。
专业的晶型药物团队

核心团队拥有近20年晶型制剂开发和产业化经验,无论是创新药还是仿制药,快速突破技术难点,取得先机。
The company has developed solid-state improved formulations and obtained patents for over 50 types of drugs.
Pipelines
Solid State Research

Improving drug absorption through solid-state technology is the foundation of all innovative technologies at Xinyang Weikang.

More >
Innovative Improved Drugs
Our company strategically focuses on developing high-end formulations, successfully completing numerous advanced oral film formulations, and establishing a systematic approach to formulation development.
More  >
CDMO
We are the only integrated domestic platform specializing in crystalline formulation production, strictly adhering to GMP standards. We specialize in scaling up research and commercial production of various dosage forms including oral films, topical formulations, and solid formulations.
More >
Nycrist Phamatech Co.,Ltd
Tel:19129598229  
       19129598368(Mr.Lee)
       19926561149(Mrs.Chen)
       19926414326(Mr.Liu)


Headquarters Address: Building A3, Guanming Technology Park, No. 3009 Guangming Avenue, Fenghuang Community, Fenghuang Street, Guangming District, Shenzhen


Production Base Address: Weiguang Life Science Park, Guangming District, Shenzhen


Business Team

Business Contact

Wechat
Recruitment
HR:0755-23411222
      19145082504(Mr.lee)

Address
Follow us
WeChat
TEL:19129598229